Abstract
The in vitro antibacterial activity of the new quinoline derivative ciprofloxacin (BAY 0 9867) was evaluated in comparison to norfloxacin and nalidixic acid using 495 clinical strains of gram-negative and gram-positive bacteria. The compound was highly active againstEnterobacteriaceae, with MICs ranging from 0.008 mg/l to 4 mg/l, whereas the MICs of norfloxacin ranged from 0.03 mg/l to 16 mg/l. All strains ofPseudomonas aeruginosa andAcinetobacter calcoaceticus were inhibited with a concentration of 2 mg/l ciprofloxacin and 32 mg/l norfloxacin. Ciprofloxacin was also active against gram-positive cocci. The MICs forStaphylococcusaureus, Staphylococcus epidermidis, andStreptococcus faecalis ranged from 0.008 to 2.0 mg/l. The activity of ciprofloxacin was only slightly influenced by inoculum size, whereas an acid environment caused a noticeable decrease in the activity. Ciprofloxacin would seem to be a promising antibacterial agent for the treatment of urinary tract infection.
Similar content being viewed by others
References
Lesher, G. Y., Froelich, E. J., Gruett, M. D., Bailey, J. H., Brundage, R. P.: 1,8-naphthyridine derivates. A new class of chemotherapeutic agents. Journal of Medicinal and Pharmaceutical Chemistry 1962, 5: 1063–1065.
Shimizu, M., Nakamura, S., Takase, Y., Kurobe, N.: Pipemidic acid: absorption, distribution, and excretion. Antimicrobial Agents and Chemotherapy 1975, 7: 441–446.
Kershaw, N. J., Leigh, D. A.: The antibacterial and pharmacological activity of oxolinic acid (Prodoxol). Journal of Antimicrobial Chemotherapy 1975, 1: 311.
Lumish, R. M., Norden, C. W.: Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid. Antimicrobial Agents and Chemotherapy 1975, 7: 159–163.
Giamarellou, H. G., Jackson, G.: Antibacterial activity of cinoxacin in vitro. Antimicrobial Agents and Chemotherapy 1975, 7: 688.
Braveny, I., Machka, K.: In vitro activity of rosoxacin (Win 35 213) againstNeisseria gonorrhoeae. Arzneimittel-Forschung 1980, 9: 1476–1478.
Soussy, C. J., Thibault, M., Kitzis, M. D., Acar, J. F., Duval, J., Chabbert, Y. A.: Activité antibactérienne comparée de six quinolones. Annales de Microbiologie 1977, 128 B: 19–33.
Thibault, M., Koumaré, B., Soussy, C. J., Duval, J.: Relations structure-activité dans le groupe des quinolones: études de l'activité antibacteriénne de deux nouveaux composés. Annales de Microbiologie 1981, 132 A: 267–281.
Norrby, S. R., Jonsson, M.: Antibacterial activity of norfloxacin. Antimicrobial Agents and Chemotherapy 1983, 23: 15–18.
Ito, A., Hirai, K., Inoue, M., Koga, H., Suzue, S., Irikura, T., Mitsuhashi, S.: In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrobial Agents and Chemotherapy 1980, 17: 103–108.
Kloos, W. E., Smith, P. B.: Staphylococci. In: Lenette, E. H., Balows, A., Hausler, W. J., Truant, J. P. (ed.): Manual of clinical microbiology. American Society for Microbiology, Washington, D.C. 1980, p. 83–87.
Facklam, R. R.: Streptococci and aerococci. In: Lenette, E. H., Balows, A., Hausler, W. J., Truant, J. P. (ed.): Manual of Clinical Microbiology. American Society for Microbiology, Washington, D.C. 1980, p. 88–110.
Washington, J. A., Sutter, V. L.: Dilution susceptibility test: agar and macro-broth dilution procedures. In: Lenette, E. H., Balows, A., Hausler, W. J., Truant, J. P. (ed.): Manual of Clinical Microbiology. American Society for Microbiology, Washington, D.c. 1980, p. 453–458.
Gavan, T. L., Barry, A. L.: Microdilution test procedures. In: Lenette, E. H., Balows, A., Hausler, W. J., Truant, J. P. (ed.): Manual of Clinical Microbiology. American Society for Microbiology, Washington, D.C. 1980, p. 459–462.
Bauernfeind, A.: Progress in chemotherapeutic heterocyclic carbonic acids. Drugs under Experimental and Clinical Research 1983, 9 (in press).
Bauernfeind, A., Grümmer, G.: Biochemical effects of nalidixic acid onEscherichia coli. Chemotherapia 1965/66, 10: 95–102.
Bauernfeind, A.: Mode of action of nalidixic acid. Antibiotics and Chemotherapy 1971, 17: 122–136.
Goss, W. A., Deitz, W. H., Cook, T. M.: Mechanism of action of nalidixic acid onEscherichia coli. II. Inhibition of desoxyribonucleic acid synthesis. Journal of Bacteriology 1965, 89: 1068–1074.
Boppana, V. K., Swanson, B. N.: Determination of norfloxacin a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography. Antimicrobial Agents and Chemotherapy 1982, 21: 808–810.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bauernfeind, A., Petermüller, C. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. Eur. J, Clin. Microbiol. 2, 111–115 (1983). https://doi.org/10.1007/BF02001575
Issue Date:
DOI: https://doi.org/10.1007/BF02001575